Get started
Author

José Manuel Ruiz Morales

Observed names: J. Morales, Jose M. Ruiz Morales, Jose Manuel Ruiz Morales
ORCID: 0000-0003-3512-7776
Observed ORCID: 0000-0003-3512-7776
OpenAlex ID: A5018420726
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
2022 · Ziad Bakouny, Talal El Zarif, et al. · European Urology · 115
PDF
Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.
2020 · Ziad Bakouny, Wanling Xie, et al. · Journal of Clinical Oncology · 21
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
2017 · Steven M. Yip, Jose M. Ruiz Morales, et al. · Kidney Cancer · 19
PDF
The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).
2021 · Andrew Lachlan Schmidt, Wanling Xie, et al. · Journal of Clinical Oncology · 14
Nephroblastoma in Older Adult: Case Report and Review of Literature
2024 · Ricardo Fernández-Ferreira, Jose Manuel Torres-Zazueta, et al. · Case Reports in Oncology · 9
PDF
Impact of Testicular Germ Cell Tumor Laterality on Recurrence-Free Survival in the Mexican Population
2021 · David Davila Dupont, Daniel Motola Kuba, et al. · World Journal of Oncology · 4
PDF
Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database
2024 · Kripa Guram, Jiaming Huang, et al. · Cancer · 3
PDF
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
2016 · Jose Manuel Ruiz Morales, J Connor Wells, et al. · Journal of Clinical Oncology · 2
Hierbas, medicina herbolaria y su impacto en la práctica clínica
2010 · Raúl Carrillo Esper, Bolivar Lara Caldera, et al. · Médica Sur · 2
Outcomes of metastatic chromophobe renal cell carcinoma (chrRCC) in the targeted therapy era: Results from the International Metastatic Renal Cell Cancer Database Consortium.
2016 · Steven Yip, Jose Manuel Ruiz Morales, et al. · Journal of Clinical Oncology · 1
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
2022 · Kripa Guram, Jiaming Huang, et al. · Journal of Clinical Oncology
Benefit of prophylactic anticoagulation before and during first-line chemotherapy on patients with metastatic germ cell tumors.
2020 · Christian Daniel Fankhauser, Ben Tran, et al. · Journal of Clinical Oncology
Recurrence rates of patients with positive surgical margins after partial nephrectomy for renal cell carcinoma
2019 · T. Guimaraes, C. Muresan, et al. · European Urology Supplements
CLOVIZ: Clinical outcomes visualization of IMDC criteria in metastatic renal cell carcinoma for patient-centered decision making.
2017 · Anobel Y. Odisho, Sumanta K. Pal, et al. · Journal of Clinical Oncology
Predictive and Prognostic Markers in Metastatic Renal Cell Carcinoma
2017 · José Manuel Ruiz Morales, Daniel Y. C. Heng · Springer eBooks
Large retroperitoneal lymphadenopathy (RPLN) and increased risk of venous thromboembolism (VTE) in patients (pts) with metastatic germ cell tumours (mGCT): A Global Germ Cell Cancer Group (G3) Study.
2016 · Ben Tran, Jose Manuel Ruiz Morales, et al. · Journal of Clinical Oncology
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
2016 · Jose Manuel Ruiz Morales, Marcin Swierkowski, et al. · Journal of Clinical Oncology
Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) as markers of response rate to chemotherapy in lung adenocarcinoma.
2015 · Jose Manuel Ruiz Morales, Rita Dorantes Heredia, et al. · Journal of Clinical Oncology
Works count: 18
Citation count: 190
H-index: 5
I10-index: 4
Year
Topic
Type